China’s Ministry of Commerce (MOFCOM) and the Ministry of Science and Technology (MOST) jointly launched a public consultation on proposed revisions to the Catalogue of Technologies Prohibited or Restricted from Export, seeking to add 40 technologies across three strategic fields – artificial intelligence (AI), biopharmaceuticals and photovoltaics. Comments will be accepted from October 16 through November 15, 2026, after which the ministries are expected to finalize the revised catalogue.
Policy Snapshot
| Item | Detail |
|---|---|
| Issuing Authorities | Ministry of Commerce (MOFCOM); Ministry of Science and Technology (MOST) |
| Action | Public consultation on revisions to China’s Catalogue of Technologies Prohibited or Restricted from Export |
| Consultation Window | 16 Oct 2026 – 15 Nov 2026 |
| Proposed Scope | 40 technologies across AI, biopharmaceuticals and photovoltaics |
| Biopharma Additions | Five technologies covering cell and gene therapy, small nucleic acid drugs and pathogenic microorganisms |
| Facilitation Measures | Automatic licensing and similar streamlined measures for outbound licensing without ownership transfer |
| Next Steps | Review of public comments; issuance of the final revised catalogue (timeline not disclosed) |
Proposed Additions – Scope & Key Technologies
- Three Priority Fields: The draft revision would bring 40 technologies under export prohibition or restriction, spanning artificial intelligence, biopharmaceuticals and photovoltaics – sectors at the center of China’s industrial policy and global technology competition.
- Biopharmaceutical Coverage: Five biopharma technologies are proposed for the catalogue, relating to cell and gene therapy, small nucleic acid drugs and pathogenic microorganisms – advanced modalities where China has built substantial domestic R&D capability.
- Facilitated Licensing Pathway: For outbound licensing models that do not involve a transfer of ownership, facilitated measures such as automatic licensing will apply – signaling a calibrated approach that keeps commercial licensing channels open while tightening control over outright ownership transfers.
Compliance Requirements – Technology Export Registration
Technology export operators must register with the Technology Trade Management Information Application on the MOFCOM Unified Business System Platform (https://ecomp.mofcom.gov.cn) before exporting any technology listed in the announcement’s annex. Registration is required in the following scenarios:
- Ownership Transfer: Transfer of technology ownership to overseas parties, such as intellectual property transfers.
- Overseas Licensing: Licensing of domestic technology for use overseas, such as intellectual property licensing.
- Change of Control: Change of the owner or actual controller of domestic technology to an overseas entity – a definition broad enough to capture cross‑border M&A and restructuring transactions involving covered technologies.
- Other Designated Circumstances: Any other scenarios for which MOFCOM explicitly requires registration through notices or other means.
Market Impact & Outlook
- Biopharma Out‑Licensing Watch: Companies pursuing cross‑border deals in cell and gene therapy, small nucleic acid drugs or pathogenic microorganism technologies should map their pipelines against the proposed annex and prepare registration workflows well ahead of deal execution.
- Deal‑Structuring Implications: The explicit carve‑out for licensing without ownership transfer – with automatic licensing facilitation – suggests that pure out‑licensing arrangements may face a lighter administrative burden than IP assignments or control‑changing transactions.
- AI & Solar Sectors: With photovoltaics and AI also in scope, the revision reinforces China’s pattern of using export control lists to manage technology outflows in sectors where it holds global manufacturing or research leadership.
- Compliance Readiness: Export operators are advised to verify platform registration on the MOFCOM Unified Business System and monitor the consultation docket; the final catalogue may differ from the draft now open for comment through 15 Nov 2026.
Forward‑Looking Statements
This brief contains forward‑looking statements regarding the proposed revisions to China’s Catalogue of Technologies Prohibited or Restricted from Export, including the consultation timeline, the scope of technologies ultimately added, and the application of facilitated licensing measures. Actual outcomes may differ materially based on public comments received, inter‑agency deliberations, and subsequent regulatory notices. The proposals described remain subject to change until formally issued.-Fineline Info & Tech
